Considering the number of chemical barrier proteins that showed altered expression between patients with OSCC and controls, the presence of the tumor in the oral cavity could alter the expression profile and/or secretion of AMPs and other barrier components, and could also alter the defense function of the barrier. This evidence concerns the gene ADSL and neoplasm.